CDK12 and neoplasm: Further metabolite heatmap analysis revealed that CDK12 knockout led to a significant increase in metabolic products related to glycolysis, glutaminolysis and nucleotide biosynthesis, while a substantial decrease in metabolites involved in fatty acid beta‐oxidation (Figure 2C), indicating that CDK12 deficiency significantly alters the energy metabolism of tumour cells.